Breaking News
May 3, 2019 - Vaping and Smoking May Signal Greater Motivation to Quit
May 3, 2019 - Dementia looks different in brains of Hispanics
May 3, 2019 - Short-Staffed Nursing Homes See Drop In Medicare Ratings
May 3, 2019 - Study of teens with eating disorders explores how substance users differ from non-substance users
May 3, 2019 - Scientists develop new video game that may help in the study of Alzheimer’s
May 3, 2019 - Arc Bio introduces Galileo Pathogen Solution product line at ASM Clinical Virology Symposium
May 3, 2019 - Cornell University study uncovers relationship between starch digestion gene and gut bacteria
May 3, 2019 - How to Safely Use Glucose Meters and Test Strips for Diabetes
May 3, 2019 - Anti-inflammatory drugs ineffective for prevention of Alzheimer’s disease
May 3, 2019 - Study tracks Pennsylvania’s oil and gas waste-disposal practices
May 3, 2019 - Creating a better radiation diagnostic test for astronauts
May 3, 2019 - Vegans are often deficient in these four nutrients
May 3, 2019 - PPDC announces seed grants to develop medical devices for children
May 3, 2019 - Study maps out the frequency and impact of water polo head injuries
May 3, 2019 - Research on Reddit identifies risks associated with unproven treatments for opioid addiction
May 3, 2019 - Good smells may help ease tobacco cravings
May 3, 2019 - Medical financial hardship found to be very common among people in the United States
May 3, 2019 - Researchers develop multimodal system for personalized post-stroke rehabilitation
May 3, 2019 - Study shows significant mortality benefit with CABG over percutaneous coronary intervention
May 3, 2019 - Will gene-editing of human embryos ever be justifiable?
May 3, 2019 - FDA Approves Dengvaxia (dengue vaccine) for the Prevention of Dengue Disease in Endemic Regions
May 3, 2019 - Why Tonsillitis Keeps Coming Back
May 3, 2019 - Fighting the opioid epidemic with data
May 3, 2019 - Maggot sausages may soon be a reality
May 3, 2019 - Deletion of ATDC gene prevents development of pancreatic cancer in mice
May 2, 2019 - Targeted Therapy Promising for Rare Hematologic Cancer
May 2, 2019 - Alzheimer’s disease is a ‘double-prion disorder,’ study shows
May 2, 2019 - Reservoir bugs: How one bacterial menace makes its home in the human stomach
May 2, 2019 - Clinical, Admin Staff From Cardiology Get Sneak Peek at Epic
May 2, 2019 - Depression increases hospital use and mortality in children
May 2, 2019 - Vicon and NOC support CURE International to create first gait lab in Ethiopia
May 2, 2019 - Researchers use 3D printer to make paper organs
May 2, 2019 - Viral infection in utero associated with behavioral abnormalities in offspring
May 2, 2019 - U.S. Teen Opioid Deaths Soaring
May 2, 2019 - Opioid distribution data should be public
May 2, 2019 - In the Spotlight: “I’m learning every single day”
May 2, 2019 - 2019 Schaefer Scholars Announced
May 2, 2019 - Podcast: KHN’s ‘What The Health?’ Bye-Bye, ACA, And Hello ‘Medicare-For-All’?
May 2, 2019 - Study describes new viral molecular evasion mechanism used by cytomegalovirus
May 2, 2019 - SLU study suggests a more equitable way for Medicare reimbursement
May 2, 2019 - Scientists discover first gene involved in lower urinary tract obstruction
May 2, 2019 - Researchers identify 34 genes associated with increased risk of ovarian cancer
May 2, 2019 - Many low-income infants receive formula in the first few days of life, finds study
May 2, 2019 - Global study finds high success rate for hip and knee replacements
May 2, 2019 - Taking depression seriously: What is it?
May 2, 2019 - With Head Injuries Mounting, Will Cities Put Their Feet Down On E-Scooters?
May 2, 2019 - Scientists develop small fluorophores for tracking metabolites in living cells
May 2, 2019 - Study casts new light into how mothers’ and babies’ genes influence birth weight
May 2, 2019 - Researchers uncover new brain mechanisms regulating body weight
May 2, 2019 - Organ-on-chip systems offered to Asia-Pacific regions by Sydney’s AXT
May 2, 2019 - Adoption of new rules drops readmission penalties against safety net hospitals
May 2, 2019 - Kids and teens who consume zero-calorie sweetened beverages do not save calories
May 2, 2019 - Improved procedure for cancer-related erectile dysfunction
May 2, 2019 - Hormone may improve social behavior in autism
May 2, 2019 - Alzheimer’s disease may be caused by infectious proteins called prions
May 2, 2019 - Even Doctors Can’t Navigate Our ‘Broken Health Care System’
May 2, 2019 - Study looks at the impact on criminal persistence of head injuries
May 2, 2019 - Honey ‘as high in sugars as table sugar’
May 2, 2019 - Innovations to U.S. food system could help consumers in choosing healthy foods
May 2, 2019 - FDA Approves Mavyret (glecaprevir and pibrentasvir) as First Treatment for All Genotypes of Hepatitis C in Pediatric Patients
May 2, 2019 - Women underreport prevalence and intensity of their own snoring
May 2, 2019 - Concussion summit focuses on science behind brain injury
May 2, 2019 - Booker’s Argument For Environmental Justice Stays Within The Lines
May 2, 2019 - Cornell research explains increased metastatic cancer risk in diabetics
May 2, 2019 - Mount Sinai study provides fresh insights into cellular pathways that cause cancer
May 2, 2019 - Researchers to study link between prenatal pesticide exposures and childhood ADHD
May 2, 2019 - CoGEN Congress 2019: Speakers’ overviews
May 2, 2019 - A new strategy for managing diabetic macular edema in people with good vision
May 2, 2019 - Sagent Pharmaceuticals Issues Voluntary Nationwide Recall of Ketorolac Tromethamine Injection, USP, 60mg/2mL (30mg per mL) Due to Lack of Sterility Assurance
May 2, 2019 - Screen time associated with behavioral problems in preschoolers
May 2, 2019 - Hormone reduces social impairment in kids with autism | News Center
May 2, 2019 - Researchers synthesize peroxidase-mimicking nanozyme with low cost and superior catalytic activity
May 2, 2019 - Study results of a potential drug to treat Type 2 diabetes in children announced
May 2, 2019 - Multigene test helps doctors to make effective treatment decisions for breast cancer patients
May 2, 2019 - UNC School of Medicine initiative providing unique care to dementia patients
May 2, 2019 - Nestlé Health Science and VHP join forces to launch innovative COPES program for cancer patients
May 2, 2019 - Study examines how our brain generates consciousness and loses it during anesthesia
May 2, 2019 - Transition Support Program May Aid Young Adults With Type 1 Diabetes
May 2, 2019 - Study shows how neutrophils exacerbate atherosclerosis by inducing smooth muscle-cell death
May 2, 2019 - Research reveals complexity of how we make decisions
Neuroengineering in three-dimensional brain-like microenvironments

Neuroengineering in three-dimensional brain-like microenvironments

An illustrated model compares a 2D stiff environment (left) with a 3D soft brain-like microenvironment (right) to reprogram neurons from somatic cells in the lab. Biophysical and biomechanical cues from the 3D microenvironment can boost direct neuronal reprogramming. Credit: Nature Biomedical Engineering, doi: 10.1038/s41551-018-0260-8

The human brain is organized of highly complex and expansive cellular and neuronal networks, but the existing scientific understanding of the developing brain is proportionately limited. Neuroengineering is an evolving field that employs advanced technology to manipulate neurons. The discipline can develop disease models of the central and peripheral nervous system to grasp neurological disorders, and produce next-generation biomaterials for neural tissue engineering. The ability to directly reprogram and convert mature cells such as fibroblasts (somatic cells) into neurons has also presented promising therapeutic potential. Technology for neuroengineering aims to design and create a broad range of applications to regulate neurons.

Neuroscientists have recently shown that brain extracellular matrix (BEM) decellularized from human brain tissue can simplify the conversion of primary mouse embryonic fibroblasts directly into induced neuronal (iN) cells in the lab. The iN cells generated on BEM substrates were transplanted in the brain of an animal model of ischemic stroke, leading to significant improvements in locomotive behaviors. The study also showed that combining 3-D BEM hydrogels with microfluidics could recreate brain-like microenvironments with higher efficacy to boost direct reprogramming and neuronal conversion, to promote functional recovery of animals after cell transplantation. The research is published in Nature Biomedical Engineering.

During neuronal reprogramming, the engineered 3-D system is believed to stimulate Yes-associated protein (YAP) and histone modifications for mechanosensitive signaling. The 3-D BEM hydrogel may also provide microenvironmental memory to retain functional phenotypes of the induced neuronal (iN) cells acquired during the conversion process. In the study, Seung-Woo Cho and co-workers first extracted brain extracellular matrix (ECM) from donor-human brain tissue to create a solubilized mixture of brain-specific native components. The solution was then used to develop and test 2-D surface coatings or 3-D systems to culture fibroblasts undergoing direct neuronal programming in the lab.

The illustrated neuroengineering procedure: decellularization of native brain tissue to produce solubilized brain extracellular matrix (BEM) to create 2D and 3D BEM platforms to reprogram fibroblasts into functional neurons. Credit: Nature Biomedical Engineering, doi: 10.1038/s41551-018-0260-8.

Direct conversion of mature somatic cells into different cell types, as seen in this instance with fibroblasts to neurons, in the presence of tissue-specific transcription factors, is known as trans-differentiation. In contrast to typical viral delivery systems, plasmids were used as the biomedical delivery vehicle of choice to transfect neuron tissue-specific elements, including BAM factors, via electroporation into the fibroblasts for induced neuronal transdifferentiation. The study showed that BEM significantly accelerated direct neuronal reprogramming, since induced neurons showed electrophysiological functions and mature neuronal marker expression as early as 14 days under laboratory conditions of cell differentiation. Immunocytochemistry and genetic analyses showed improved growth and differentiation with BEM compared to conventional biomaterials such as laminin and fibronectin, often used to fabricate 2-D extracellular matrix (ECM) coatings.

Neuroengineering in Three-dimensional Brain-like Microenvironments
Immunocytochemistry results: by day 14, the population of iN cells that stained positive for both neuron specific class III tubulin (Tuj1) and highly mature neuronal phenotype markers synapsin I (SYN1) or post synaptic density protein 95 (PSD-95) was greater in the 0.01 mg/ml BEM group than in the laminin group (LN) or in the laminin-fibronectin (LN+FN) group. DAPI (blue) stains nuclei. The region within the white box is magnified and displayed in the yellow square. BEM enhanced the direct neuronal conversion of primary fibroblasts to generate iN cells at an optimal concentration of 0.01 mg/ml. Credit: Nature Biomedical Engineering, doi: 10.1038/s41551-018-0260-8.

After completing extensive gene expression profiles and electrophysiological tests to characterize iN cells in the lab, scientists transplanted BEM-based iN cells into an adult mouse model of ischemic stroke exhibiting hypoxic brain injury to observe their therapeutic potential. In addition to neurogenesis, the paracrine effects of iN cell transplantation restored motor coordination and locomotor movement in the mice, demonstrating therapeutic efficacy.

Interestingly, cells cultured on 3-D BEM hydrogels showed higher expression levels of neuronal markers compared to 2-D BEM, indicating that biomimetic brain-like microenvironments can provide optimal biochemical and biophysical cues to guide cell reprogramming. Researchers then ingeniously combined 3-D BEM hydrogels with a microfluidic system (3-D µBEM), to amplify the autocrine and paracrine signaling of iN cells in a confined microenvironment and boost neuronal transdifferentiation.

Immunostaining analysis of iN cell cultures in multiple 3D materials, comparing conventional collagen (Col) and Matrigel (Mat) with 3D BEM, the expression of neuronal markers (Tuj1 and microtubule associated protein-2 MAP2) was significantly increased in the 3D BEM group. Credit: Nature Biomedical Engineering, doi: 10.1038/s41551-018-0260-8.

When such iN cells reprogrammed within brain-like 3-D µBEM environments were collected and transplanted in an ischemic stroke mouse model, functional recovery and therapeutic efficacy were noted. To illuminate the underlying the molecular mechanisms, scientists proposed that biophysical cues in a 3-D brain-like microenvironment may specifically induce YAP (Yes-associated protein) localization to the cellular cytoplasm to promote neuronal transdifferentiation. In contrast, stiff 2-D environments induced nuclear YAP localization, repressing neurogenesis-related gene expression, as observed in the study.

Understanding the molecular mechanisms of direct neural reprogramming for implantation in an animal model of ischemic stroke: a) immunostaining YAP (green) to quantify YAP localization in 2D and 3D conditions, b) tracking Dil-labelled (red, long-term tracer of neurons) iN cells generated from 3D µBEM at day 7 after cell injection in the striatum and cortex within the ischemic brain of an animal model. Credit: Nature Biomedical Engineering, doi: 10.1038/s41551-018-0260-8.

The study sheds light on the molecular mechanisms underlying direct neurogenesis, together with strategies to design and develop optimized biomaterials for improved neural reprogramming, reproducible in the lab. Brain-like 3-D biomimetic microenvironments can provide biochemical, biophysical, mechanical and epigenetic stimuli to efficiently reprogram neurons. Key insights from the study can be translated in the future to design and engineer a synthetic brain-like matrix to generate safe iN cells for regenerative and medical applications in neuroengineering.


Explore further:
Direct conversion of non-neuronal cells into nerve cells

More information:
Three-dimensional brain-like microenvironments facilitate the direct reprogramming of fibroblasts into therapeutic neurons www.nature.com/articles/s41551-018-0260-8 Jin et al, 11 July 2018, Nature Biomedical Engineering.

Liver extracellular matrix providing dual functions of two-dimensional substrate coating and three-dimensional injectable hydrogel platform for liver tissue engineering pubs.acs.org/doi/10.1021/bm4015039 Lee et al, 2014, Biomacromolecules.

Heart repair by reprogramming non-myocytes with cardiac transcription factors www.ncbi.nlm.nih.gov/pmc/articles/PMC3367390/ Song et al, 2012, Nature.

In vivo reprogramming of murine cardiac fibroblasts into induced cardiomyocytes www.ncbi.nlm.nih.gov/pmc/articles/PMC3369107/ Qian et al, 2012, Nature.

High-efficiency cellular reprogramming with microfluidics www.nature.com/articles/nmeth.3832 Luni et al, 2016, Nature Methods.

Biophysical regulation of epigenetic state and cell reprogramming www.nature.com/articles/nmat3777 Downing et al, 2013, Nature Materials.

3-D niche microarrays for systems-level analyses of cell fate www.nature.com/articles/ncomms5324 Ranga et al, 2014, Nature Communications.

Substratum-induced differentiation of human pluripotent stem cells reveals the coactivator YAP is a potent regulator of neuronal specification www.pnas.org/content/111/38/13805 Musah et al, 2014, Proceedings of the National Academy of Sciences.

Tagged with:

About author

Related Articles